Dyskinesia pp 64-71 | Cite as

Is Tardive Dyskinesia a Unique Disorder?

  • C. D. Marsden
Part of the Psychopharmacology Supplementum book series (PSYCHOPHARM, volume 2)


The role of neuroleptics in causing the tardive dyskinesia syndrome is controversial. To properly assess the contribution of drugs as the etiology of dyskinesias, the effects of aging, the natural history of psychosis, and characteristics of spontaneous dyskinesias must be considered. Though the buccolinguo-masticatory triad is seen more often in tardive than in spontaneous dyskinesias, these two disorders have many symptoms in common. Other dyskinesias, such as idiopathic and tardive dystonia or tardive Tourette’s syndrome and dyskinesias in untreated schizophrenia, are poorly understood. Chronic neuroleptic treatment may only precipitate TD in those already predisposed to develop such movement disorders. Tardive dyskinesia is not a unique movement disorder, but rather spans several clinical and epidemiological phenomena which must be considered in a balanced evaluation of how much of the permanent dyskinesias should be attributed to neuroleptic drugs.


Movement Disorder Tardive Dyskinesia Point Prevalence Neuroleptic Drug Task Force Report 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Jenner P, Marsden CD (1983) Neuroleptic and tardive dyskinesia. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven, New York, pp 223–253Google Scholar
  2. Kahlbaum KL (1973) Catatonia. Johns Hopkins University Press, BaltimoreGoogle Scholar
  3. Kane JM, Smith JM (1982) Tardive dyskinesia. Prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 39: 473–481PubMedGoogle Scholar
  4. Klawans HL, Barr A (1982) Prevalence of spontaneous lingual-facial-buccal dyskinesia in the elderly. Neurology 32: 558–559PubMedGoogle Scholar
  5. Klawans HL, Bergen D, Bruyn GW, Paulson GW (1978) Neuroleptic-induced tardive dyskinesias in nonpsychotic patients. Arch Neurol 30: 338–339Google Scholar
  6. Kraepelin EL (1907) Die Psychiatrie. 7th ed. English edition: McMillan, LondonGoogle Scholar
  7. Kraepelin EL (1919) Textbook of psychiatry, vol 3, dementia praecox, Livingstone, Edinburgh, part 2Google Scholar
  8. Marsden CD, Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease. Grune and Stratton, New York, pp 219–266Google Scholar
  9. Owens DGC, Johnstone EC, Frith CD (1982) Spontaneous involuntary disorders of movement in neuroleptic treated and untreated chronic schizophrenics — prevalence, severity and distributions. Arch Gen Psychiatry 39: 452–461PubMedGoogle Scholar
  10. Smith JM, Baldessarini RJ (1980) Change in prevalence, severity and recovery of tardive dyskinesia with age. Arch Gen Psychiatry 37: 1368–1373PubMedGoogle Scholar
  11. Smith JM, Kucharski KT, Eblen C, Knutsen E, Linn C (1979) An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 64: 99–104PubMedCrossRefGoogle Scholar
  12. Tardive Dyskinesia (1980) Task force report 18 of the American Psychiatric Association, WashingtonGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • C. D. Marsden
    • 1
  1. 1.University Department of NeurologyInstitute of Psychiatry and King’s College Hospital Medical SchoolLondonEngland

Personalised recommendations